Concepedia

Author

Matilde Bocci

École Polytechnique Fédérale de LausanneORCID

Also Known As

Bocci, Matilde, M. Bocci, Matilde Bocci

39

Publications

231

Citations

9

H-Index

5

Concepts

All Affiliations

École Polytechnique Fédérale de LausannePhilogen (Italy)Philochem (Switzerland)University of MünsterUniversity Hospital Münster
MB

About

Matilde Bocci is an author at École Polytechnique Fédérale de Lausanne specializing in tumor biology, tumor microenvironment, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

21

2

Cell Biology

1

1

21

3

Pharmacology

1

1

21

4

Tumor Biology

1

1

21

5

Tumor Microenvironment

1

1

21

Matilde Bocci

×

7

Publications

183

Citations

7

H-Index

YearCitations

A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake

Andrea Galbiati, Aureliano Zana, Matilde Bocci,

Journal of Nuclear Medicine

2022

62

A Comparative Analysis of Fibroblast Activation Protein-Targeted Small Molecule–Drug, Antibody–Drug, and Peptide–Drug Conjugates

Aureliano Zana, Claudia Puig-Moreno, Matilde Bocci,

Bioconjugate Chemistry

2023

28

Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors

Aureliano Zana, Andrea Galbiati, Ettore Gilardoni,

Clinical Cancer Research

2022

21

In vivo activation of FAP-cleavable small molecule-drug conjugates for the targeted delivery of camptothecins and tubulin poisons to the tumor microenvironment

Matilde Bocci, Aureliano Zana, Lucrezia Principi,

Journal of Controlled Release

2024

21

Preclinical Evaluation of<sup>177</sup>Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors

Andrea Galbiati, Matilde Bocci, Domenico Ravazza,

Journal of Nuclear Medicine

2024

21

Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention

Andrea Galbiati, Matilde Bocci, Silvia Gervasoni,

Journal of Medicinal Chemistry

2024

18

Tumor-Targeted Interleukin 2 Boosts the Anticancer Activity of FAP-Directed Radioligand Therapeutics

Andrea Galbiati, Paulina Dorten, Ettore Gilardoni,

Journal of Nuclear Medicine

2023

12

Page 1